1. Fisher DE biology of melanoma;Ostrowski;Hematol. Oncol. Clin. N. Am.,2021
2. Cancer statistics, 2023;Siegel;CA Cancer J. Clin.,2023
3. Division of Cancer Control and Population Sciences (DCCPS) - National Cancer Institute, Surveillance, Epidemiology, and End Results (SEER) Program Populations (2000-2018), National Institutes of Health USA, 2021. www.seer.cancer.gov/popdata.
4. Adjuvant nivolumab versus ipilimumab in resected Stage III or IV melanoma;Weber;N. Engl. J. Med.,2017
5. Adjuvant dabrafenib plus trametinib in Stage III BRAF -mutated melanoma;Long;N. Engl. J. Med.,2017